S&P 500
(1.26%) 5 127.79 points
Dow Jones
(1.18%) 38 676 points
Nasdaq
(1.99%) 16 156 points
Oil
(-1.22%) $77.99
Gas
(5.65%) $2.15
Gold
(0.02%) $2 310.10
Silver
(-0.16%) $26.79
Platinum
(0.37%) $966.20
USD/EUR
(-0.35%) $0.929
USD/NOK
(-1.07%) $10.87
USD/GBP
(-0.11%) $0.797
USD/RUB
(0.36%) $91.45

Realaus laiko atnaujinimai Avecho Biotechnology Ltd [AVE.AX]

Birža: ASX Pramonė: Pharmaceuticals, Biotechnology & Life Sciences
Atnaujinta3 geg. 2024 @ 08:45

0.00% $ 0.00400

Live Chart Being Loaded With Signals

Commentary (3 geg. 2024 @ 08:45):

Avecho Biotechnology Limited, a biotechnology company, develops, produces, and sells products using its patented platform technology, Targeted Penetration Matrix (TPM) drug delivery system for the pharmaceutical, skin care, animal health, and nutrition industries...

Stats
Šios dienos apimtis 484 448
Vidutinė apimtis 5.20M
Rinkos kapitalizacija 12.68M
EPS $0 ( 2024-02-27 )
Kita pelno data ( $0 ) 2024-05-30
Last Dividend $0.00878 ( 1997-05-19 )
Next Dividend $0 ( N/A )
P/E 0
ATR14 $0 (0.00%)

Tūris Koreliacija

Ilgas: -0.43 (neutral)
Trumpas: 0.00 (neutral)
Signal:(53.048) Neutral

Avecho Biotechnology Ltd Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Avecho Biotechnology Ltd Koreliacija - Valiuta/Žaliavos

The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )

Avecho Biotechnology Ltd Finansinės ataskaitos

Annual 2023
Pajamos: $473 551
Bruto pelnas: $-222 490 (-46.98 %)
EPS: $-0.00150
FY 2023
Pajamos: $473 551
Bruto pelnas: $-222 490 (-46.98 %)
EPS: $-0.00150
FY 2022
Pajamos: $1.13M
Bruto pelnas: $793 118 (70.23 %)
EPS: $-0.00130
FY 2021
Pajamos: $1.06M
Bruto pelnas: $677 486 (63.94 %)
EPS: $-0.00324

Financial Reports:

No articles found.

Avecho Biotechnology Ltd Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

Avecho Biotechnology Ltd Dividend Information - No Dividend Player

Dividend Sustainability Score: 0 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future
Information
First Dividend $0.00878 1997-05-19
Last Dividend $0.00878 1997-05-19
Next Dividend $0 N/A
Payout Date 1997-06-06
Next Payout Date N/A
# dividends 1 --
Total Paid Out $0.00878 --
Avg. Dividend % Per Year 0.00% --
Score 0.01 --
Div. Sustainability Score 0
Div.Growth Potential Score 0
Div. Directional Score 0 --
Next Divdend (Est)
(2024-05-04)
$0 Estimate 0.00 %
Dividend Stability
0.00 Very Bad
Dividend Score
0.01
Pay Frequency
Insufficient data to determine frequency
Yearly Payout
Year Amount Yield

Dividend Commentary

The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.

Top 10 dividend Companies for ASX

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
TPG.AX Ex Dividend Knight 2023-09-12 Semi-Annually 0 0.00%
CYC.AX Ex Dividend Junior 2023-09-01 Semi-Annually 0 0.00%
NUF.AX Ex Dividend Junior 2023-05-25 Annually 0 0.00%
FMG.AX Ex Dividend Knight 2023-09-04 Semi-Annually 0 0.00%
PSQ.AX Ex Dividend Junior 2023-09-21 Annually 0 0.00%
ASX.AX Ex Dividend Knight 2023-09-07 Semi-Annually 0 0.00%
IGO.AX Ex Dividend Knight 2023-09-13 Annually 0 0.00%
SGM.AX Ex Dividend Junior 2023-10-03 Annually 0 0.00%
CDA.AX Ex Dividend Knight 2023-09-05 Semi-Annually 0 0.00%
MFG.AX Ex Dividend Knight 2023-08-23 Semi-Annually 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM-7.261.500-10.00-10.00[0 - 0.5]
returnOnAssetsTTM-0.4701.200-10.00-10.00[0 - 0.3]
returnOnEquityTTM-0.8021.500-10.00-10.00[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM8.300.80010.008.00[1 - 3]
quickRatioTTM7.830.80010.008.00[0.8 - 2.5]
cashRatioTTM6.531.50010.0010.00[0.2 - 2]
debtRatioTTM0.0239-1.5009.60-10.00[0 - 0.6]
interestCoverageTTM-298.851.000-10.00-10.00[3 - 30]
operatingCashFlowPerShareTTM-0.001002.00-0.000334-0.000669[0 - 30]
freeCashFlowPerShareTTM-0.001002.00-0.000502-0.00100[0 - 20]
debtEquityRatioTTM0.0275-1.5009.89-10.00[0 - 2.5]
grossProfitMarginTTM-0.4701.000-10.00-10.00[0.2 - 0.8]
operatingProfitMarginTTM-9.691.000-10.00-10.00[0.1 - 0.6]
cashFlowToDebtRatioTTM-18.161.000-10.00-10.00[0.2 - 2]
assetTurnoverTTM0.06470.800-2.90-2.32[0.5 - 2]
Total Score-2.73

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM-3.691.000-0.4740[1 - 100]
returnOnEquityTTM-0.8022.50-6.44-10.00[0.1 - 1.5]
freeCashFlowPerShareTTM-0.001002.00-0.000334-0.00100[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM-0.001002.00-0.000334-0.000669[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM0.1151.500-2.570[0.5 - 2]
operatingCashFlowSalesRatioTTM-6.721.000-10.000[0.1 - 0.5]
Total Score-2.43

Avecho Biotechnology Ltd

Avecho Biotechnology Limited, a biotechnology company, develops, produces, and sells products using its patented platform technology, Targeted Penetration Matrix (TPM) drug delivery system for the pharmaceutical, skin care, animal health, and nutrition industries. It offers TPM and Vital ET products for use in drug delivery and cosmetic formulations; and develops TPM/Oxymorphone and TPM/Oxycodone. The company's human health portfolio covers delivery of pharmaceutical products through gels, injectables, and patches. It also provides non-antibiotic feed additive products to enhance feed efficiency and the health of livestock animals. The company has a collaboration with Lambert Initiative at the University of Sydney to conduct a study to examine whether topically applied cannabidiol can provide relief from symptoms of osteoarthritis. It serves customers in Australia, Switzerland, India, and internationally. The company was formerly known as Phosphagenics Limited and changed its name to Avecho Biotechnology Limited in May 2019. Avecho Biotechnology Limited was incorporated in 1992 and is based in Clayton, Australia.

Apie Signalai gyvai

Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.

Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.